Vālenz Health

Vālenz Health announced a leadership change on June 1, 2026. Vālenz Health appointed Ontellus’s former CEO Vince Cole as Chief Executive Officer, succeeding Rob Gelb, to position the company for its next phase of growth and expansion.

What changed

Vince Cole was named Chief Executive Officer. Rob Gelb, who spent seven and a half years at the company, will transition to the role of Non-Executive Chairman of the Board of Directors.

• Leader: Vince Cole
• Role: Chief Executive Officer
• Effective: Not specified in the announcement
• Announcement date: June 1, 2026

Leadership background

Cole has more than three decades of executive leadership experience and most recently served as Chief Executive Officer of Ontellus. He previously was CEO, Americas, of Charles Taylor and of Crawford and Company, and held executive positions at Activa Medical, Aggio Medical, Genworth Financial, and General Electric.

The mandate

Vālenz Health said Cole’s appointment follows a succession process aimed at positioning the company for its next phase of growth and expansion. Cole said he looked forward to working with the team to expand impact, strengthen partnerships, and continue delivering on the company’s mission.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Vālenz Health leadership announcement.